Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 6/20 | 0.64 |
| ▸ | CA1 | P00915 | 6/20 | 0.64 |
| ▸ | CA2 | P00918 | 6/20 | 0.64 |
| ▸ | CA7 | P43166 | 6/20 | 0.64 |
| ▸ | CA9 | Q16790 | 6/20 | 0.64 |
| ▸ | CA14 | Q9ULX7 | 6/20 | 0.64 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | BID | P55957 | 4/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 4/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 3/20 | 0.41 |
| ▸ | BAK1 | Q16611 | 3/20 | 0.41 |
| ▸ | KAT8 | Q9H7Z6 | 3/20 | 0.41 |
| ▸ | EP300 | Q09472 | 2/20 | 0.41 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.41 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.41 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24040372 | 0.82 | CA12 (0.61) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5603402 | 0.79 | CA1 (1.00) | CA12CA1CA2CA7CA9 | |
| SCHEMBL224031 | 0.79 | CA1 (1.00) | CA12CA1CA2CA7CA9 | |
| SCHEMBL18920884 | 0.77 | CA12 (0.94) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8920126 | 0.77 | CA1 (0.94) | CA12CA1CA2CA7CA9 | |
| Water SCHEMBL30558201 | 0.77 | CA1 (0.94) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8213147 | 0.77 | CA1 (0.94) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8921906 | 0.77 | CA1 (0.94) | CA12CA1CA2CA7CA9 | |
| Hydrochloric Acid SCHEMBL8394452 | 0.77 | CA1 (0.94) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27310020 | 0.77 | CA1 (0.94) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11179306-B2 | Use of salicylic acid derivatives as prodesquamating active agent | L'OREAL (FR) | 2021-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11179306-B2 | Use of salicylic acid derivatives as prodesquamating active agent | HRH1, SUCNR1, PTGS1 | CA12 2028/4885CA1 1567/4885CA2 721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.